tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics Cash Flow

SMMT's free cash flow for Q3 2024 was $-30.36M. For the 2024 fiscal year, SMMT's free cash flow was decreased by $-34.46M and operating cash flow was $-30.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -76.76M$ -41.58M$ -72.59M$ -48.11M$ -20.75M
Investing Cash Flow
$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow
$ ―$ ―$ ―$ ―$ ―
End Cash Position
$ ―$ ―$ ―$ ―$ ―
Free Cash Flow
$ -76.66M$ -42.21M$ -72.89M$ -48.53M$ -21.09M
Currency in USD

Summit Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis